Aerie pharmaceuticals to participate in the cantor global healthcare conference

Durham, n.c.--(business wire)--aerie pharmaceuticals, inc. (nasdaq: aeri), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced that the benjamin f. mcgraw, iii, pharm.d., interim executive chairman and david a. hollander, m.d., m.b.a., chief r&d officer, will participate in a fireside discussion at the
AERI Ratings Summary
AERI Quant Ranking